glp-1 not covered by insurance Medicare covers GLP-1s for $50/month starting July 2026 The GLP-1 Knowledge Gap |
Description
FDA, U.S

Extra caution is warranted for people with: Gastroparesis or delayed gastric emptying GLP-1 medications significantly delay gastric emptying and are generally not recommended in severe gastroparesis

1,961 participants with BMI of 30+ (or 27+ with at least one weight-related condition) received either semaglutide 2.4 mg or placebo weekly for 68 weeks, alongside lifestyle intervention
Due to the time needed to resolve the cross-cutting issues and then select and prepare a group of early cases for trial, the first GLP-1 lawsuits are unlikely to go before federal juries until at least 2027
